Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on August 15, 2012. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Formalin Fixed Tissue Blocks and Melanoma Lesion Pathology Reports

Awarded
NCI-120179-LGFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541380
New
SLED
Fire Flow Testing Services
Solicitation # 121589
The Washington Suburban Sanitary Commission (WSSC) is soliciting sealed responses for solicitation number 121589 to establish a Fire Flow Testing Services program. The contractor will be responsible for the planning, locating, inspection, and testing of fire hydrants and associated water distribution components across various pressure zones in Maryland to evaluate hydraulic performance. Key technical tasks include measuring static pressure, residual pressure, and flow rates, as well as performing traffic setup and maintenance for residential, county, and state roads. The project involves a base quantity of 1,500 fire flow tests, 3,000 hydrant inspections, and 3,000 valve inspections, with pricing options for three additional years. To be considered, bidders must possess at least five years of experience as a prime contractor and provide at least two crews, each led by a professional with three years of expertise. Crucially, at least one crew member must hold a current Maryland Water Distribution System Operator D-1 license. Bidders must also provide a comprehensive equipment list and adhere to AWWA and MDE standards, including specific requirements for chlorinated water discharge. The contract will be awarded to the lowest responsive and responsible bidder who meets all minimum qualifications. Submissions are due by November 30, 2026, via the WSSC eProcurement Portal. Contract administration includes strict quality assurance requirements, requiring the implementation of a QA/QC plan and immediate reporting of residual pressures falling below 20 psi. Contractors must maintain significant insurance coverages, including Commercial General Liability, Pollution Liability, and Errors and Omissions, each with limits up to 2,000,000 dollars. Payment is processed via ACH or procurement credit card within 30 days of acceptance. Additionally, the contract incorporates a Mid-Atlantic Purchasing Team clause, allowing other public entities to utilize the resultant contract terms and pricing.
Utility Services Department

POSTED

about 20 hours ago

DEADLINE

in about 1 month

AI Contract Overview

Show more

The National Cancer Institute, through the Division of Cancer Epidemiology and Genetics, intends to award a sole source, firm fixed price contract to the University of L'Aquila in Italy. The primary objective of this procurement is the collection of formalin fixed tissue blocks, melanoma lesion pathology reports, and related clinical data. This effort supports ongoing research into the genetic and environmental determinants of melanoma by correlating molecular changes across tumors with previously analyzed epidemiological and genetic risk factors. The contract period of performance is scheduled from September 28, 2012, to September 27, 2013, with an option for one additional twelve month extension. The University of L'Aquila was selected as the sole source due to its unique access to the specific patient records and biospecimens required for the study, as well as its specialized expertise in melanoma pathology and data management. This acquisition is processed under simplified acquisition procedures with a NAICS code of 541380.

General Info

Agency

N/A

Contract Value

$24,800

NAICS

541380 - Testing Laboratories and Services

Place of Performance

ITA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Laura GlocknerContract Specialist

Full Description

Show more
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Boulevard, EPS Suite 600, Room 6070, Rockville, MD 20852, UNITED STATES. Description The National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Genetic Epidemiology Branch (GEB), plans to procure on a sole source basis services from University of L'Aquila, Department of Biotechnological and Applied Clinical Sciences, Via Vetoio, Coppito 2, 67100, l'Aquila, Italy, for the collection of formalin fixed tissue blocks and melanoma lesion pathology reports. This acquisition will be processed in accordance with simplified acquisition procedures in FAR Part 13.106 (b)(1). The North American Industry Classification System code is 541380 the business size standard is $14.0 million. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Period of Performance: Performance shall be from September 28, 2012 - September 27, 2013 with one (1) twelve month option period. It has been determined that there is no opportunity to acquire green products or services under this contract. The Division of Cancer Epidemiology and Genetics (DCEG) is an intramural research program of the National Cancer Institute (NCI), National Institutes of Health (NIH) that conducts population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The GEB has been investigating epidemiological and genetic factors associated with melanoma risk in a case-control study of melanoma conducted at the University of L'Aquila. The purpose of this requirement is to support the collection of formalin fixed tissue blocks and related pathology reports and clinical data from melanoma cases previously examined for epidemiological and genetic variant associations with melanoma risk. The Genetic Epidemiology Branch (GEB) has successfully conducted an analysis of epidemiological and genetic factors associated with melanoma risk in a case-control study of melanoma conducted at the University of L'Aquila, Department of Biotechnological and Applied Clinical Sciences. The GEB needs to collect melanoma tissue blocks from the same melanoma cases from which the branch has examined epidemiological and genetic risk factors, in order to correlate these data with molecular changes across tumors. The Department of Biotechnological and Applied Clinical Sciences has great experience in following screening criteria for nevi and pigmentation characteristics and epidemiological data collection. The Department's scientists have been trained in the recognition of dysplastic nevi and melanoma as well as pathological features of melanoma lesions and can ensure continuity in the research. The Department of Biotechnological and Applied Clinical Sciences also has surgeons that can verify the melanoma diagnoses by reviewing the pathology reports from the pathologists of the L'Aquila University. In addition, the Department's scientists have expertise in the practical aspects involved in the management of data, clinical forms, informed consents, and biospecimens according to NCI standard and operating procedures and will ensure optimal quality of the collected data. Finally, the Department of Biotechnological and Applied Clinical Sciences has access to medical and pathological records from the same melanoma patients previously analyzed at NCI, which is pivotal to the completion of this project. Based upon these factors the Department of Biotechnological and Applied Clinical Sciences at the University of L'Aquila is the only know contractor that can fulfill the requirements of this contract. This is not a solicitation for competitive quotations. However, if any interested party believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisition on or before 11:00 AM EST on August 30, 2012. No electronic capability statements will be accepted (i.e. email or fax) an original and one copy must be sent to the NCI Office of Acquisition to the address stated above. All questions must be in writing and can be faxed +1 (555) 000-0000 or emailed to Laura Glockner, Contract Specialist at contact@example.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA) through SAM.gov. No collect calls will be accepted. Please reference solicitation number NCI-120179-LG on all correspondence.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS